<DOC>
	<DOCNO>NCT01577693</DOCNO>
	<brief_summary>The purpose study determine bioavailability 0.5mg dutasteride novel formulation compare currently market 0.5mg dutasteride soft gel capsule fast healthy male subject .</brief_summary>
	<brief_title>Study Compare Bioavailability Dutasteride Novel Formulation Form Soft Gel Capsule Form Healthy Male Subjects</brief_title>
	<detailed_description>The purpose study determine bioavailability 0.5mg dutasteride novel formulation compare currently market 0.5mg dutasteride soft gel capsule fast healthy male subject . This open-label , single dose , randomize , two-period crossover study healthy male subject . Subjects receive single oral dose 0.5mg novel dutasteride formulation single oral dose 0.5mg dutasteride soft gel capsule fast state . Each dose study medication separate 28-day washout period . Blood sample pharmacokinetic analysis take regular interval dose . Safety assess measurement blood pressure , heart rate , laboratory data , review adverse event . The study enrol approximately 35 healthy male subject ensure 30 subject complete study . The study conduct USA .</detailed_description>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Dutasteride</mesh_term>
	<criteria>Healthy determine responsible experienced physician . Males 20 45 year age inclusive , time signing informed consent form . Male subject female partner childbearing potential must agree use one contraception . Body mass index within range 1830 kg/m2 ( inclusive ) ; weight range 5595 kg ( inclusive ) . Capable give write informed consent . Single QTcB &lt; 450 msec . Aspartate aminotransferase ( AST ) , alanine aminotransferase ( ALT ) , alkaline phosphatase , bilirubin le equal 1.5xULN ( isolated bilirubin &gt; 1.5xULN acceptable bilirubin fractionate direct bilirubin &lt; 35 % ) . History postural hypotension , dizziness , poor hydration , vertigo , vasovagal reaction sign symptom orthostasis . Current chronic history liver disease , know hepatic biliary abnormality ( exception Gilbert 's syndrome asymptomatic gallstone ) . A positive prestudy Hepatitis B surface antigen positive Hepatitis C antibody result within 3 month screen A positive test human immunodeficiency virus ( HIV ) antibody . Subject mentally legally incapacitate . Use prescription nonprescription drug , include vitamin , herbal dietary supplement . History sensitivity dutasteride , component thereof drug class history drug allergy . History sensitivity heparin heparininduced thrombocytopenia The subject participate clinical trial 30 day , 5 halflives twice duration biological effect investigational product ( whichever longer ) . Exposure four new chemical entity within 12 month prior first dose day . A positive prestudy drug/alcohol screen . History regular alcohol consumption . Consumption red wine , grapefruit juice , grapefruit related hybrid , jufen grape . The subject donate blood blood product excess 500 mL within 56 day period . Urinary cotinine level indicative smoke history regular use tobacco nicotinecontaining product within 6 month . Unwillingness inability follow procedure outline protocol .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>dutasteride</keyword>
	<keyword>cross study</keyword>
	<keyword>bioavailability</keyword>
</DOC>